Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA.

Objective: Gestational diabetes mellitus (GDM) and type 2 diabetes (T2 DM) presents varying metabolic patterns across populations, yet the extent to which these differences appear at diagnosis remains unclear. This study examines whether baseline metabolic profiles differ among pregnant women from diverse racial and ethnic backgrounds. Our objective was to determine whether these metabolic differences may influence diabetes management during pregnancy. Study Design: We conducted a two‑year retrospective study of 200 insulin‑naïve women at NYU Langone hospital at Brooklyn, NY, diagnosed with GDM and or T2DM in the third trimester. The diagnostic criteria were standard two‑step testing , 50‑g glucose challenge (1Hr. GCT, cut off 135mg./DL) followed by a 100‑g Oral glucose tolerance test (OGTT). Baseline fasting labs included glucose, C‑peptide, and lipid profiles, with insulin sensitivity estimated using IS‑HOMA (C‑peptide). Management followed standardized diet, exercise, Metformin when appropriate, and weight‑based basal–bolus insulin titrated to fasting glucose levels 85–90 mg/dL and 2‑hour postprandial 115–120 mg/dL. Results: Significant race/ethnicity‑specific metabolic phenotype differences emerged. Hispanic-Latina women and American born Black women had higher BMI, higher fasting C‑peptide, and lower insulin sensitivity, whereas Asian (Southeast and East Indian) and Caribbean/Haitian Black women showed lower C‑peptide but higher insulin sensitivity. Lipid patterns also varied. There was no statistically significant difference in birthweight across groups. Conclusion: In this cohort, we observed distinct metabolic profiles across racial and ethnic groups at the time of GDM or T2DM diagnosis in pregnancy. These differences, particularly in insulin sensitivity, C‑peptide levels, and BMI, suggest that metabolic phenotype varies meaningfully by race and ethnicity. Incorporating these patterns into clinical decision‑making may help refine diabetes management strategies and support more equitable perinatal outcomes.

Authors

Institutions

Publication Details

Journal
American Journal of Perinatology
Published
2026-11-19
DOI
https://doi.org/10.1055/a-3008-4657
Primary Topic
Gestational Diabetes Research and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA.

Jacklyn Tse, Supriya D. Mahajan, Daniel Martingano, Dimitrios S. Mastrogiannis et al.
American Journal of Perinatology
Gestational Diabetes Research and Management
article

Metabolic Profiles and insulin therapy requirements among pregnant women with Gestational Diabetes mellitus and Type 2 Diabetes across self-identified Race/ethnic groups in Brooklyn NY, USA.

Jacklyn Tse, Supriya D. Mahajan, Daniel Martingano, Dimitrios S. Mastrogiannis, Shailini Singh, Antonia Olodipo
article en

Abstract

Objective: Gestational diabetes mellitus (GDM) and type 2 diabetes (T2 DM) presents varying metabolic patterns across populations, yet the extent to which these differences appear at diagnosis remains unclear. This study examines whether baseline metabolic profiles differ among pregnant women from diverse racial and ethnic backgrounds. Our objective was to determine whether these metabolic differences may influence diabetes management during pregnancy. Study Design: We conducted a two‑year retrospective study of 200 insulin‑naïve women at NYU Langone hospital at Brooklyn, NY, diagnosed with GDM and or T2DM in the third trimester. The diagnostic criteria were standard two‑step testing , 50‑g glucose challenge (1Hr. GCT, cut off 135mg./DL) followed by a 100‑g Oral glucose tolerance test (OGTT). Baseline fasting labs included glucose, C‑peptide, and lipid profiles, with insulin sensitivity estimated using IS‑HOMA (C‑peptide). Management followed standardized diet, exercise, Metformin when appropriate, and weight‑based basal–bolus insulin titrated to fasting glucose levels 85–90 mg/dL and 2‑hour postprandial 115–120 mg/dL. Results: Significant race/ethnicity‑specific metabolic phenotype differences emerged. Hispanic-Latina women and American born Black women had higher BMI, higher fasting C‑peptide, and lower insulin sensitivity, whereas Asian (Southeast and East Indian) and Caribbean/Haitian Black women showed lower C‑peptide but higher insulin sensitivity. Lipid patterns also varied. There was no statistically significant difference in birthweight across groups. Conclusion: In this cohort, we observed distinct metabolic profiles across racial and ethnic groups at the time of GDM or T2DM diagnosis in pregnancy. These differences, particularly in insulin sensitivity, C‑peptide levels, and BMI, suggest that metabolic phenotype varies meaningfully by race and ethnicity. Incorporating these patterns into clinical decision‑making may help refine diabetes management strategies and support more equitable perinatal outcomes.

American Journal of Perinatology
Rutgers, The State University of New Jersey (US), Albert Einstein College of Medicine (US), NYU Langone Health (US), Hackensack Meridian Health (US), University at Buffalo, State University of New York (US)
Gestational Diabetes Research and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon